188 related articles for article (PubMed ID: 10705013)
21. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability.
Vallis KA; Benjamin IS; Munro AJ; Adam A; Foster CS; Williamson RC; Kerr GR; Price P
Radiother Oncol; 1996 Oct; 41(1):61-6. PubMed ID: 8961369
[TBL] [Abstract][Full Text] [Related]
22. Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma.
Buskirk SJ; Gunderson LL; Adson MA; Martinez A; May GR; McIlrath DC; Nagorney DM; Edmundson GK; Bender CE; Martin JK
Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2013-23. PubMed ID: 6436203
[TBL] [Abstract][Full Text] [Related]
23. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG
Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935
[TBL] [Abstract][Full Text] [Related]
24. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome.
Valentini V; Morganti AG; De Franco A; Coco C; Ratto C; Battista Doglietto G; Trodella L; Ziccarelli L; Picciocchi A; Cellini N
Cancer; 1999 Dec; 86(12):2612-24. PubMed ID: 10594856
[TBL] [Abstract][Full Text] [Related]
25. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
Ishii H; Furuse J; Nagase M; Kawashima M; Ikeda H; Yoshino M
Hepatogastroenterology; 2004; 51(58):954-7. PubMed ID: 15239222
[TBL] [Abstract][Full Text] [Related]
26. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
Leung JT; Kuan R
Australas Radiol; 1997 May; 41(2):151-4. PubMed ID: 9153812
[TBL] [Abstract][Full Text] [Related]
27. Biliary tree malignancies: the University of Minnesota experience.
Lee CK; Barrios BR; Bjarnason H
J Surg Oncol; 1997 Aug; 65(4):298-305. PubMed ID: 9274796
[TBL] [Abstract][Full Text] [Related]
28. Intraluminal brachytherapy in bile duct carcinomas.
Leung J; Guiney M; Das R
Aust N Z J Surg; 1996 Feb; 66(2):74-7. PubMed ID: 8602818
[TBL] [Abstract][Full Text] [Related]
29. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G
Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409
[TBL] [Abstract][Full Text] [Related]
30. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma.
Buskirk SJ; Gunderson LL; Schild SE; Bender CE; Williams HJ; McIlrath DC; Robinow JS; Tremaine WJ; Martin JK
Ann Surg; 1992 Feb; 215(2):125-31. PubMed ID: 1312319
[TBL] [Abstract][Full Text] [Related]
31. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
Ben-David MA; Griffith KA; Abu-Isa E; Lawrence TS; Knol J; Zalupski M; Ben-Josef E
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):772-9. PubMed ID: 17011452
[TBL] [Abstract][Full Text] [Related]
32. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
[TBL] [Abstract][Full Text] [Related]
33. Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study.
Autorino R; Mattiucci GC; Ardito F; Balducci M; Deodato F; Macchia G; Mantini G; Perri V; Tringali A; Gambacorta MA; Tagliaferri L; Giuliante F; Morganti AG; Valentini V
Anticancer Res; 2016 Feb; 36(2):737-40. PubMed ID: 26851032
[TBL] [Abstract][Full Text] [Related]
34. Biliary tree malignancies.
Erickson BA; Nag S
J Surg Oncol; 1998 Mar; 67(3):203-10. PubMed ID: 9530894
[TBL] [Abstract][Full Text] [Related]
35. Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial.
Schoppmeyer K; Miethe S; Wiedmann M; Liebmann A; Hauss J; Mossner J; Caca K; Witzigmann H; Hildebrandt G
Am J Clin Oncol; 2006 Dec; 29(6):576-82. PubMed ID: 17148994
[TBL] [Abstract][Full Text] [Related]
36. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer.
Kim S; Kim SW; Bang YJ; Heo DS; Ha SW
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):414-9. PubMed ID: 12243816
[TBL] [Abstract][Full Text] [Related]
37. Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma.
Mattiucci GC; Autorino R; D'Agostino GR; Deodato F; Macchia G; Perri V; Tringali A; Morganti AG; Mutignani M; Valentini V
Crit Rev Oncol Hematol; 2014 Apr; 90(1):58-67. PubMed ID: 24289902
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
Bisello S; Buwenge M; Palloni A; Autorino R; Cellini F; Macchia G; Deodato F; Cilla S; Brandi G; Tagliaferri L; Cammelli S; Valentini V; Morganti AG; Mattiucci GC
Anticancer Res; 2019 Jun; 39(6):3095-3100. PubMed ID: 31177154
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers.
Bonet Beltrán M; Roth AD; Mentha G; Allal AS
BMC Cancer; 2011 Jun; 11():267. PubMed ID: 21702920
[TBL] [Abstract][Full Text] [Related]
40. 125I interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree.
Dobelbower RR; Merrick HW; Ahuja RK; Skeel RT
Cancer; 1986 Nov; 58(10):2185-95. PubMed ID: 3756765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
